glucaric acid has been researched along with Benign Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amet, S; Deray, G; Janus, N; Launay-Vacher, V; Mahi, L; Rey, JB; Rouillon, L; Scotte, F; Zakin, L | 1 |
| Abbasi, S; Abdel-Razeq, H; Abdelelah, H; Jaber, R; Saadi, I | 1 |
| Gemici, C; Mayadagli, A; Ozden, S; Ozyurt, H; Tepetam, H; Yaprak, G; Yetmen, O | 1 |
| Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A | 1 |
| Auerbach, M; Ballard, H | 1 |
| Hanausek, M; Kiliańska, ZM; Walaszek, Z; Zółtaszek, R | 1 |
| Hanausek, M; Kowalczyk, MC; Kowalczyk, P; Narog, M; Slaga, TJ; Spears, E; Walaszek, Z; Yoshimi, N; Zoltaszek, R | 1 |
| Cheng, D; Hnatowich, D; Liu, G; Liu, X; Liu, Y; Rusckowski, M; Wang, Y | 1 |
| BOYLAND, E; WALLACE, DM | 1 |
| CARR, AJ; MARSH, CA | 1 |
| Hanausek, M; Slaga, TJ; Walaszek, Z | 1 |
| Laman, CA; Rodgers, GM; Silverstein, SB | 1 |
| Gershanovich, ML; Livshits, ME; Makhnova, EV | 1 |
| Fujita, Y; Hachino, Y; Hasegawa, K; Horiuchi, T; Masui, Y; Morimoto, S; Shimidzu, K; Shono, Y; Tabuse, K; Yamaguchi, T | 1 |
| Birgegård, G; Hedenus, M | 1 |
| Maezawa, S; Matsuoka, S; Ohira, S; Saito, T; Sakuma, M; Wakui, A | 1 |
| McLean, AE | 1 |
5 review(s) available for glucaric acid and Benign Neoplasms
| Article | Year |
|---|---|
Intravenous iron in oncology.
Topics: Anemia; Antineoplastic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Neoplasms | 2008 |
[The biological role of D-glucaric acid and its derivatives: potential use in medicine].
Topics: Animals; Apoptosis; Glucaric Acid; Glucuronidase; Humans; Neoplasms; Oxidative Stress; Risk Factors | 2008 |
Detoxifying cancer causing agents to prevent cancer.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Biomarkers; Chemoprevention; Diet; Dietary Supplements; Glucaric Acid; Glucuronidase; Humans; Neoplasms; Neoplasms, Experimental; Prognosis; Risk Assessment; Sensitivity and Specificity; Treatment Outcome | 2003 |
The role of iron supplementation during epoietin treatment for cancer-related anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Drug Administration Schedule; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Iron, Dietary; Maltose; Neoplasms; Randomized Controlled Trials as Topic | 2009 |
Cancer and nutrition (review).
Topics: Alcohol Drinking; Animals; Antipyrine; Carcinogens; Cytochrome P-450 Enzyme System; Diet; Dietary Fats; Dietary Proteins; England; Genetics; Glucaric Acid; Half-Life; Humans; Kidney; Life Expectancy; Liver; Male; Middle Aged; Neoplasms; Nutritional Physiological Phenomena; Pharmaceutical Preparations; Pharmacology; Public Health; Smoking; Toxins, Biological | 1976 |
12 other study(ies) available for glucaric acid and Benign Neoplasms
| Article | Year |
|---|---|
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.
Topics: Anemia, Iron-Deficiency; Central Venous Catheters; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Infusions, Intravenous; Maltose; Neoplasms; Practice Patterns, Physicians'; Surveys and Questionnaires | 2013 |
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Transfusion; Feasibility Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome | 2013 |
Is there any role of intravenous iron for the treatment of anemia in cancer?
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies | 2017 |
Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Administration, Topical; Animals; Anticarcinogenic Agents; Biomarkers; Carcinogens; Deoxyguanosine; Dermatitis, Contact; Female; Glucaric Acid; Glucuronates; Glucuronidase; HSP90 Heat-Shock Proteins; Hyperplasia; Inflammation Mediators; Interleukin-1alpha; Leukocyte Count; Mice; Mice, Inbred SENCAR; Neoplasms; Skin | 2011 |
A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG.
Topics: Animals; Female; Fluorodeoxyglucose F18; Glucaric Acid; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous; Tumor Cells, Cultured | 2011 |
Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds.
Topics: Administration, Oral; Glucaric Acid; Glucose; Glucuronidase; Humans; Neoplasms; Urinary Bladder Neoplasms | 1957 |
CHANGES IN ENZYME ACTIVITY, RELATED TO D-GLUCARIC ACID SYNTHESIS, WITH AGE, PREGNANCY AND MALIGNANCY.
Topics: Aging; Animals; Animals, Newborn; Carbohydrate Metabolism; Female; Fetus; Glucaric Acid; Glucuronates; Lactones; Liver; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Oxidoreductases; Pathology; Pregnancy; Rats | 1965 |
Parenteral iron therapy: a single institution's experience over a 5-year period.
Topics: Acetaminophen; Anemia, Iron-Deficiency; Diphenhydramine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Parenteral; Iron Metabolism Disorders; Iron-Dextran Complex; Kidney Diseases; Male; Menorrhagia; Neoplasms; Premedication; Retrospective Studies; Telangiectasia, Hereditary Hemorrhagic; United States; von Willebrand Diseases | 2005 |
[Use of Venofer in management of anemia in cancer patients].
Topics: Adult; Aged; Anemia; Disease Progression; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sucrose; Time Factors; Treatment Outcome | 2006 |
[Improvement of urinary d-glucaric acid assay and its application].
Topics: Antineoplastic Agents; Biomarkers; Creatinine; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Monitoring; Glucaric Acid; Humans; Liver; Neoplasms | 2008 |
Correlation between the level of urinary D-glucaric acid and the degree of activation of masked compound (FT-207) in cancer patients.
Topics: Adult; Aged; Biotransformation; Cytochrome P-450 Enzyme System; Esophageal Neoplasms; Female; Fluorouracil; Glucaric Acid; Humans; Kinetics; Male; Microsomes, Liver; Middle Aged; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Sugar Acids; Tegafur | 1981 |